| Cutaneous drug reactions CK Svensson, EW Cowen, AA Gaspari Pharmacological reviews 53 (3), 357-379, 2001 | 286 | 2001 |
| Therapeutic drug monitoring in saliva: an update RK Drobitch, CK Svensson Clinical pharmacokinetics 23 (5), 365-379, 1992 | 256 | 1992 |
| Representation of American blacks in clinical trials of new drugs CK Svensson Jama 261 (2), 263-265, 1989 | 222 | 1989 |
| Free drug concentration monitoring in clinical practice: rationale and current status CK Svensson, MN Woodruff, JG Baxter, D Lalka Clinical pharmacokinetics 11, 450-469, 1986 | 197 | 1986 |
| A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions TP Reilly, LH Lash, MA Doll, DW Hein, PM Woster, CK Svensson Journal of Investigative Dermatology 114 (6), 1164-1173, 2000 | 189 | 2000 |
| Clinical pharmacokinetics of nicotine CK Svensson Clinical pharmacokinetics 12, 30-40, 1987 | 152 | 1987 |
| Vancomycin pharmacokinetics in burn patients and intravenous drug abusers MJ Rybak, LM Albrecht, JR Berman, LH Warbasse, CK Svensson Antimicrobial agents and chemotherapy 34 (5), 792-795, 1990 | 149 | 1990 |
| Biotransformation of drugs in human skin CK Svensson Drug Metabolism and Disposition 37 (2), 247-253, 2009 | 131 | 2009 |
| Effect of food on hepatic blood flow: Implications in the “food effect” phenomenon CK Svensson, DJ Edwards, PM Mauriello, SH Barde, AC Foster, RA Lanc, ... Clinical Pharmacology & Therapeutics 34 (3), 316-323, 1983 | 129 | 1983 |
| Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin S Roychowdhury, CK Svensson The AAPS journal 7, E834-E846, 2005 | 112 | 2005 |
| Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone TP Reilly, FH Bellevue III, PM Woster, CK Svensson Biochemical pharmacology 55 (6), 803-810, 1998 | 108 | 1998 |
| Inhibition of drug metabolism by quinolone antibiotics DJ Edwards, SK Bowles, CK Svensson, MJ Rybak Clinical pharmacokinetics 15, 194-204, 1988 | 101 | 1988 |
| Clinical pharmacokinetics of pethidine: 1982 D Edwards, CK Svensson, JP Visco, D Lalka Clinical pharmacokinetics 7, 421-433, 1982 | 90 | 1982 |
| Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: implications for differences in adverse drug reactions TP Reilly, PM Woster, CK Svensson Journal of Pharmacology and Experimental Therapeutics 288 (3), 951-959, 1999 | 84 | 1999 |
| Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: II. Expression and role of flavin-containing monooxygenases and peroxidases PM Vyas, S Roychowdhury, SB Koukouritaki, RN Hines, SK Krueger, ... Journal of Pharmacology and Experimental Therapeutics 319 (1), 497-505, 2006 | 73 | 2006 |
| Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal … PM Vyas, S Roychowdhury, PM Woster, CK Svensson Biochemical pharmacology 70 (2), 275-286, 2005 | 71 | 2005 |
| Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes S Roychowdhury, PM Vyas, TP Reilly, AA Gaspari, CK Svensson Journal of Pharmacology and Experimental Therapeutics 314 (1), 43-52, 2005 | 70 | 2005 |
| Acetylator phenotype and genotype in patients infected with HIV: discordance between methods for phenotype determination and genotype WM O'Neil, RK Drobitch, RD MacArthur, MJ Farrough, MA Doll, ... Pharmacogenetics and Genomics 10 (2), 171-182, 2000 | 62 | 2000 |
| Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts P Bhaiya, S Roychowdhury, PM Vyas, MA Doll, DW Hein, CK Svensson Toxicology and applied pharmacology 215 (2), 158-167, 2006 | 61 | 2006 |
| Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: I. Expression and role of cytochromes P450 PM Vyas, S Roychowdhury, FD Khan, TE Prisinzano, J Lamba, ... Journal of Pharmacology and Experimental Therapeutics 319 (1), 488-496, 2006 | 54 | 2006 |
